Professor Csaba Bödör read molecular biology and Immunology at Eötvös University (Budapest, Hungary) and obtained his Ph.D. degree in molecular oncology at Semmelweis University in 2008. He developed interest in molecular pathogenesis of hematological malignancies. He spent three years in Barts Cancer Institute (London, UK) with a postdoctoral research fellowship from the European Hematology Association (EHA). After his return to Hungary, he developed a research program on genomic and epigenetic background of hematological malignancies.
Currently, he is the head of the Molecular Diagnostic Division of the Department of Pathology and Experimental Research at Semmelweis University and head of the Molecular Oncohematology Research Group at the Hungarian Centre of Excellence for Molecular Medicine.